To gain a better understanding of the molecular basis of mitochondrial (mt) encephalomyopathies, a highly heterogeneous condition, we developed a denaturing gradient gel electrophoresis-based approach that allows rapid and exhaustive screening for mutations of all 22 mt tRNA-encoding genes and their flanking regions in large cohorts of patients. This method, that detects heteroplasmy (i.e. co-existence of mutant and wild-type mtDNA species in various ratios) directly, was applied to the investigation of 35 independent patients with a disease phenotype compatible with a mitochondrial encephalomyopathy. Twenty-five of the 35 patients investigated displayed a sequence variation in at least one tRNA gene. A total of 46 different sequence variations (41 point mutations, four short insertions and one short deletion), among which 20 are new, were characterized. Forty of them were present in a homoplasmic state, whereas six were heteroplasmic. Twenty-two were located in tRNA genes, among which 10 are new homoplasmic or heteroplasmic sequence variations; 24 were located in flanking regions (12 in mRNA-encoding genes, seven of them leading to missense sequence variations; two in rRNA genes; and 10 in non-coding regions). This study demonstrates (i) the high frequency of homoplasmic tRNA gene sequence variations in our patient sample, and (ii) the existence of several polymorphic sites in tRNA gene regions that may be helpful for defining haplogroups in different populations. It relies on a screening method that can now be applied easily to other population samples.
INTRODUCTION
Human mitochondrial DNA (mtDNA) plays a crucial role in the physiology and pathology of cellular bioenergetics, by participating in the elaboration of the mitochondrial respiratory chain through the synthesis of 13 polypeptides belonging to respiratory complexes I, III, IV and V. Several mtDNA defects affecting cellular function have been described (1) . The existence of major size rearrangements in mtDNA molecules (2) may be responsible for various syndromes, among which chronic progressive external ophthalmoplegia (PEO) is the most frequent. Depletion of mtDNA molecules may cause organ-specific symptoms (3) . Pathogenic mtDNA point mutations have been found in each type of mtDNA gene (i.e. mRNA, rRNA or tRNA genes). The tRNA gene mutations cause various encephalomyopathy phenotypes including MELAS (myopathy with encephalopathy, lactic acidosis and stroke-like episodes) and MERRF [myoclonic epilepsy with ragged-red fibers (RRF)], associated with the 3243G substitution in the tRNA LeuUUR gene and the 8344G substitution in the tRNA Lys gene, respectively; numerous other familial or sporadic pathological conditions have also been described in association with >30 different point mutations in mt tRNA genes (1) . Interestingly, most mutations in tRNA genes have been identified in a heteroplasmic state, i.e. co-existence of normal and mutant mtDNAs within the same cell or tissue. The syndromes caused by major size rearrangements or tRNA gene point mutations are usually associated with muscular histopathological abnormalities, such as RRF or mosaic deficiency of cytochrome oxidase activity (i.e. COX-negative fibers) (4). However, in several patients presenting with such features, the search for a major rearrangement and already described point mutations in tRNA genes remains negative (5) , making it necessary to explore the complete sequence of all 22 tRNA genes. With this aim, we designed optimal experimental conditions to detect mt tRNA mutations in a simple, rapid, sensitive and reliable way, using denaturing gradient gel electrophoresis (DGGE) analysis of PCR-amplified fragments. Thirty-five independent patients presenting with encephalopathy or myopathy associated with ragged-red or COX-negative fibers were investigated following this procedure.
DGGE-based screening system (6) using PCR-amplified fragments containing a GC-rich tail (7, 8) was designed by means of computational simulation using the algorithms provided by Lerman et al. (9) . Complete scrutiny of mt tRNA genes was warranted by the location of these genes in the lowest melting domain at one end of the amplification fragments (8, 10) , and by use of electrophoretic conditions allowing optimal discrimination between homoduplexes and heteroduplexes, as predicted by computational analysis (9) . The nucleotide sequences of the primers and the electrophoretic conditions are provided in Table 2 .
In all but one PCR fragment, the efficiency of mutation detection was illustrated by the detection of heteroduplexes that were generated either spontaneously in heteroplasmic patients, or after mixing different PCR samples in homoplasmic patients (see Materials and Methods). Several variants were identified in each PCR fragment, except in fragment 5 (tRNA Trp region) where no sequence variation was detected in the 35 patients investigated (Table 3 ). The number of sequence variants and their relative frequency in our patient population differed widely from region to region. Table 4 summarizes which changes were found in which patient. --12  MNGIE  s  -+  -13  PEO  s  -+  +  14  limb myopathy + ataxia  s  -+  -15  PEO  s  -+  +  16  encephalopathy  s  +  --17  PEO  s  -+  +  18  limb myopathy  s  +  -+  19  PEO + stroke  s  -+  +  20  PEO  s  -+  +  21  PEO  s  +  +  +  22  encephalopathy  s  +  -+  23  PEO  oc  -+  +  24  PEO + deafness  oc  ---25  limb myopathy + encephalopathy + heart conduction trouble  oc  -+  -26  PEO + deafness + cardiomyopathy  oc  -+  +  27  limb myopathy  oc  -+  +  28  PEO  s  -+  -29  PEO + ataxia + deafness + heart conduction trouble  oc  -+  +  30  ataxia + deafness  s  +  -+  31  limb myopathy  s  -+  +  32  PEO + deafness  oc  -+  +  33  PEO + ataxia + retinitis pigmentosa  oc  -+  +  34  stroke + cardiomyopathy  s  ---35  PEO + cardiomyopathy  oc  -+  + RRF, ragged-red fibers; s, sporadic case; oc, other case(s) within the family compatible with maternal inheritance; PEO, progressive external ophthalmoplegia; DID-MOAD, diabetes insipidus, diabetes mellitus, optic atrophy and deafness; MNGIE, myopathy, neuropathy, gastrointestinal dysmotility and encephalopathy; + , present; -, absent. a Patient 9 was suspected with mitochondrial disease when giant mitochondria were detected in circulating lymphocytes originating from a splenic lymphoma. Forty-six different sequence variations (41 point mutations, four short insertions and one short deletion), among which 20 are new, were characterized. Forty of them were present in a homoplasmic state, whereas six of them were in a heteroplasmic state (gain of three Cs at 568-573, gain of seven Cs at 568-573, 3243G, 4450A, 5692C, 8344G). Twenty-two are located in tRNA genes and 24 in flanking regions (10 in non-coding regions, two in rRNA genes and 12 in mRNA-encoding genes, among which seven are missense sequence variations and five synonymous substitutions) (Table 3 ).
Heteroplasmic sequence variations
Six different heteroplasmic sequence variations (as revealed by multiple-band patterns), among which two are new, were identified in 13 different patients. Four of them are located in tRNA genes, whereas the two remaining variations consist of short insertions of different sizes in a polypyrimidine tract at position 568-573 in the D-loop region, near the tRNA Phe gene (Table 3) .
Seven patients (patients 1-7) with various clinical phenotypes (Table 1) presented with heteroplasmic profiles in the tRNA LeuUUR region (fragment 3, Fig. 1A ). In all cases, the sequence variation responsible for heteroplasmy was the 3243G mutation (MELAS mutation), as characterized by enzymatic digestion. However, two of these patients presented with a different DGGE migration pattern; sequencing revealed an additional sequence variation in a homoplasmic state in the ND1 gene: the synonymous 3336C substitution (patient 4) and the 3316A variation leading to a A4T missense mutation (patient 6, Fig. 1A ).
One patient presenting with MERRF syndrome (patient 8) displayed a heteroplasmic DGGE profile in the tRNA Lys region (fragment 10, Fig. 1B ). As expected, PCR restriction analysis revealed the 8344G point mutation usually associated with this disease (11). Previously undescribed mutations are shown in bold. Sequence variations reported for the second time are shown in normal characters. Sequence variations previously described in healthy subject populations as frequent polymorphisms (frequency of at least 1%) are shown in italics. syn: synonymous sequence variation. Another patient (patient 9), presenting with a splenic lymphoma, displayed a heteroplasmic profile in the tRNAs Ile,Gln,Met region (fragment 6), due to the 4450A sequence variation in the tRNA Met gene. The mutated species, which was identified as the predominant species in circulating leukocytes (Fig. 1C) , was also found in muscle as the minor species (12) .
A heteroplasmy in the tRNAs Ala,Asn gene region (fragment 6) was discovered in a 55-year-old patient (patient 10) with PEO, ataxia, deafness, peripheral neuropathy and hypertrophic cardiomyopathy. Sequencing revealed a point mutation in the tRNA Asn gene (5692C) that was reported previously in a patient with a similar clinical pattern (13) . Mutated and wild-type mtDNA species were equally represented, as reflected by the similar intensity of each homoduplex band (Fig. 1D) .
Three patients carried a heteroplasmic sequence variation in the tRNA Phe gene region (fragment 1). This heteroplasmy is actually due to the insertion of several cytosines (Cs) in the polyC tract at position 568-573, which is a part of the non-coding D-loop region: we found three more Cs in patient 17, and seven more Cs in patients 25 and 29.
Homoplasmic sequence variations
Forty different homoplasmic sequence variations (as revealed by single band patterns), among which 18 are new, were characterized: 18 were located in the tRNA genes and 22 in the surrounding regions (12 in structural genes, two in rRNA genes and eight in non-coding regions) ( Table 3) .
Homoplasmic variations in tRNA-encoding genes. Eighteen different homoplasmic variations were found in the tRNA genes. Nine of them are new: 1664A in tRNA Val and 10014A in tRNA Gly (patient 18); 5633T in tRNA Ala (patient 22); 7581C in tRNA Asp (patient 16); 8348G in tRNA Lys (patient 28); 10042G in tRNA Gly (patient 21); 12234G in tRNA SerAGY (patient 33); 10457C in tRNA Arg and 15913T in tRNA Thr (patient 9). The previously described 5814C substitution in the tRNA Cys gene (14) was found in one patient (patient 27) in a homoplasmic state (Fig. 1E) . In Table 5 the location of these 10 mutated nucleotides in tRNA and their phylogenetic conservation are presented. The other eight variations are frequent polymorphisms that were described previously in control subjects at a frequency of at least 1%: 7476T in tRNA SerUCN (15) , 10034C in tRNA Gly (16) , 12308G in tRNA LeuCUN (17) , 10410C in tRNA Arg (18) , 15904T (15) and 15924G (19) in tRNA Thr , 10463C in tRNA Arg and 15928A in tRNA Thr , the two latter being usually associated (15) .
Homoplasmic variations in the tRNA gene flanking regions.
In the course of the identification of mt tRNA gene mutations, we detected sequence variations in the flanking regions. Twenty-two different sequence variations, among which 10 are new, were identified: 19 substitutions, two short insertions and one short deletion. Twelve occurred in mRNA-encoding regions, one in the 12S rRNA gene, one in the 16S rRNA gene and eight in the non-coding regions (Table 3) .
Seven of the 12 sequence variations located in protein subunit genes consist of missense variations. Two of them are new: 3398C (M31T) in ND1, which is associated with the heteroplasmic 4450A mutation in tRNA Met (patient 9), and 14793G (H16R) in cytochrome b (patients 25 and 26) . The other missense variations found in our patient sample were: the previously reported 3316A leading to a A4T amino acid substitution in ND1 (20) ; 10398G, a frequent polymorphism leading to a T114A substitution in ND3 (21); 10506G leading to a T13A substitution in ND4 (22); and 14766C and 14798C, two frequent polymorphisms leading to the I7T and F18L substitutions in cytochrome b (16, 23) . The five synonymous substitutions were 3336C in ND1, 7430G in COX1, 10103G and 10400T in ND3 and 14783C in cytochrome b.
The homoplasmic variations found in the 12S and 16S rRNA genes were 1536G (patient 31) and 3197C (patients 21, 25, 26, 27, 34), respectively; it is likely that the 16S rRNA gene variation is a frequent Caucasian polymorphism, as it was found with the same frequency in our patient and control populations (data not shown). Homoplasmic variations found in the non-coding regions were gain of one C at 568-573 (patient 21); 5583T, in the short non-coding stretch between tRNA Trp and tRNA Ala genes (patient 25); 5656G, changing the non-coding base pair between tRNA Ala and tRNA Asn genes (patient 27); gain of one C at 5895-5899, in the short non-coding region between the tRNA Asn and COX1 genes (patient 28); the frequently described 9-bp deletion at 8272-8280 (24,25) (patient 21); 15954C, changing the non-coding base pair between tRNA Thr and tRNA Pro genes (patient 16); 16051G (patients 27 and 31) and 16069T (patients 9, 19, 22 and 23) in the D-loop region.
DISCUSSION

DGGE is a relevant screening method to detect mtDNA point mutations
Looking for point mutations in mtDNA is a hard task. First, such mutations may occur at any position, thereby underlining the need to develop exhaustive screening methods; second, after detecting and identifying new sequence variations, classifying them as polymorphisms or pathogenic mutations may be difficult: one needs especially to know if they are present in a homoplasmic or heteroplasmic state. Among the different screening techniques that have been proposed to study mtDNA (26-32), a DGGEbased approach using a GC-clamp and heteroduplex detection is a powerful way to overcome these two difficulties. Indeed, it relies on a screening method that is exhaustive in optimal experimental conditions (10, 33) ; in addition, it allows direct detection of a minor heteroplasmy that can escape standard molecular analyses based on direct sequencing or on the cloning of PCR-amplified fragments. The efficiency of such a screening procedure is attested to by the very large number of nucleotide variations identified in this study (Table 3) .
Most heteroplasmic DGGE patterns result from pathogenic sequence variations in tRNA genes
A heteroplasmic DGGE pattern was found in 13 out of the 35 patients investigated. In 10 of these patients, the heteroplasmy was due to a pathogenic sequence variation in a tRNA-encoding gene. The 3243G mutation in the tRNA LeuUUR gene, usually associated with MELAS, PEO or diabetes and deafness, was found in six patients presenting with these phenotypes, and in one patient (patient 3) presenting with an atypical encephalomyopathy. The 8344G mutation in the tRNA Lys gene, usually associated with MERRF, was found in one MERRF patient. The 4450A mutation in the tRNA Met gene and the previously described 5692C mutation in the tRNA Asn gene were found in one patient each. At first glance, these two mutations are very likely to be deleterious, as they change evolutionarily conserved nucleotides that are involved in the structure of the T arm of tRNA Met and the anticodon arm of tRNA Asn , respectively (12, 13) . Although the relevance of the 4450A mutation to patient 9's lymphoma remains unclear, its pathogenic character was indeed confirmed by the study of respiratory phenotype of transmitochondrial cybrids (12) . However, heteroplasmy is not an absolute hallmark of pathogenicity. Indeed, in three patients and controls, we found heteroplasmic patterns in the tRNA Phe gene region due to insertions of several Cs in the polyC tract at position 568-573. Analogous insertions of 2-6 Cs at the same site were described previously as non-pathogenic polymorphisms associated with heteroplasmy in a Caucasian haplogroup (34) .
Pathological significance of sequence variations underlying homoplasmic DGGE patterns
Heteroplasmy is a transitional state; it results from the occurrence of a mtDNA point mutation, and may lead to its fixation in a homoplasmic state in one cell, one tissue or one individual, through segregation of the mutated mtDNA species, either at random or under nuclear control (35) . The more deleterious the mutation is, the higher is the constraint exerted against the fixation of the mutated species in a homoplasmic state (36) . A homoplasmic state is, therefore, an argument against a strong pathogenic character of a mitochondrial sequence variation. However, this does not rule out a mildly deleterious consequence with a possible additive or synergistic effect in combination with other homoplasmic (37) or heteroplasmic point mutations, or major size rearrangements (38) . This might be the case for several rare homoplasmic sequence variations identified in our patient population and located in the tRNA genes and their flanking regions. Indeed, four of these sequence variations were found in association with a heteroplasmic pathogenic mutation, raising the question of their contribution to the disease phenotype. The A4T substitution in the ND1 gene, which has been reported in patients with non-insulin-dependent diabetes mellitus (20) , was found in association with the 3243G mutation in patient 6 who presented with PEO and strokes. The M31T missense variation in the ND1 gene and two other nucleotide substitutions (10457C and 15913T in tRNA Arg and tRNA Thr genes, respectively) were found together with the 4450A mutation in patient 9 presenting with a splenic lymphoma. In addition, two homoplasmic missense variations, that so far have been identified only in pathological situations, were found in three patients: the new H16R substitution (14793G) in the cytochrome b of patients 25 and 26 presenting with two different abnormal phenotypes (Table 1) , and the T13A missense variation (10506G) in the ND4L gene, which was identified in patient 20 presenting with PEO, and previously reported in one LHON patient (22) .
The 5814C substitution in the tRNA Cys gene, found in patient 27, a 60-year-old woman presenting with mild late-onset myopathy, is likely to be deleterious. According to the DGGE pattern, the muscular DNA of this patient carried the mutation in a homoplasmic state. Strikingly, the same mutation was described recently in a heteroplasmic state in the muscle of a 5-year-old child presenting with a MELAS-like syndrome (14) . Several hypotheses may explain the association of two very different phenotypes with this mutation, such as a different distribution of wild-type and mutated species in tissues of the two patients and an organ-specific pathogenicity, or the existence of various mtDNA or nuclear backgrounds.
For several other rare homoplasmic sequence variations found in the tRNA genes of our patient sample, a pathogenic contribution to the disease phenotype could not be excluded, although evaluation of phylogenetic conservation of the mutated nucleotides produced no argument for their pathogenic role (Table 5 ).
In conclusion, this study demonstrates the high frequency of homoplasmic sequence variations in human mt tRNA genes and underlines the molecular heterogeneity of mitochondrial neuromuscular disorders when no major size rearrangement of mtDNA is detected. The system used in the present study to screen for mt tRNA sequence variations allows a rapid detection of heteroplasmic and homoplasmic mutations in large groups of patients. It can now be applied easily to other patient and control populations. It may also be helpful for defining haplogroups in different populations, given its efficiency in detecting polymorphic sites.
MATERIALS AND METHODS
Patients
Thirty-five independent patients were referred to us to investigate a possible mitochondrial disease that was suspected on the basis of clinical and biological features and familial inquiry (Table 1) .
In most cases (31/35), histological and histochemical examination of a skeletal muscle biopsy revealed RRF or COX-negative fibers. No major mtDNA rearrangement was detected by Southern blotting in all 35 patients.
Extraction of DNA
In all patients, mtDNA was extracted from muscular biopsy specimens, as described (39) . In one case (patient 9), mtDNA was also obtained from white blood cells following standard techniques.
Denaturing gradient gel electrophoresis of PCR-amplified mtDNA
The melting behavior of double-stranded DNA fragments encompassing mt tRNA genes was analyzed by means of the MELT87 program (9) . This information was used to select PCR primers to amplify fragments suitable for DGGE. As the sequence of interest has to be located within the first melting domains of the fragment, a GC-rich tail of variable length was added at the 5′ end of one of the two primers (8) . Optimal experimental conditions (i.e. denaturing gradient, voltage, time length) to discriminate heteroduplexes from homoduplexes were determined for each selected fragment by means of the SQHTX program (9) . Fifteen amplification fragments, numbered 1-15, were selected to allow exhaustive DGGE screening of the 22 tRNA genes ( Table 2 ). The corresponding melting curves are available upon request.
PCR was used to obtain a high copy number of selected mt DNA regions. It was performed in a 100 µl reaction mixture containing 100 ng of total DNA as template, 0.2 pmol/µl of each primer, dNTP at a concentration of 200 µM for each and 5 U of Taq polymerase (ATGC Biotechnologies, Noisy-le-Grand, France). The amplification conditions specific to each fragment are summarized in Table 4 .
DGGEs were run in a Tris-EDTA-acetate buffer (TEA: Tris 40 mM; Na acetate 20 mM; EDTA 1 mM; H 2 O qsp), at 60_C, using a 6% polyacrylamide gel containing a gradient of denaturing agents (100% denaturant = 7 M urea and 40% formamide). The gels were stained with ethidium bromide and examined under UV light.
Direct sequencing of PCR-amplified fragments
The double-stranded DNA products generated for DGGE analysis were subjected to direct sequencing using an ABI 373A automated DNA sequencer (Perkin-Elmer Corp., Applied Biosystems Division). We used the updated Cambridge human mtDNA light strand sequence as the reference sequence (40, 41) .
Strategy for exploration of the different mt tRNA-encoding regions
Given the frequent occurrence of mutations in tRNA LeuUUR and tRNA Lys genes, the two PCR fragments encompassing these genes (regions 3 and 10, respectively) were first explored in all patients. Samples that displayed heteroplasmy in region 3 were screened for the presence of the 3243G mutation in the tRNA LeuUUR gene by restriction analysis using HaeIII. Patients that showed heteroplasmy in region 10 were tested for the most frequent mutation in the tRNA Lys gene (8344G) by enzymatic digestion of an amplified fragment generated with primer F8128-8147 (Table 2 ) and a reverse primer (5′>GGG GCA TTT CAC TGT AAA GAG GTG TTA G<3′), the 3′ sequence of which was modified to create an AluI restriction site in the presence of the 8344G mutation. When no heteroplasmic mutation was detected in fragments 3 and 10, patients were submitted to exhaustive DGGE analysis in all regions.
As the mutated species was predominant in all heteroplasmic patterns, characterization of the underlying mutation could be achieved by direct sequencing. In each region, samples with different homoplasmic DGGE patterns (i.e. different migration levels) were easily distinguished; one sample corresponding to each migration level was sequenced. PCR samples displaying identical DGGE patterns were mixed together in groups of four samples, and analyzed subsequently by DGGE after a cycle of melting and reassociating: the presence of heteroduplexes pointed to the existence of a sample with an original sequence, that was identified further by direct sequencing.
